Literature DB >> 3945834

Newborn metabolic screening: a search for "nature's experiments".

K S Roth.   

Abstract

The rationale for metabolic screening includes discovery of new diseases, development of treatment methods, determination of the true incidence of disease in order to provide genetic counseling, and relief to the taxpayer when retardation is preventable. The number of diseases for which we can now screen is large and growing and must be periodically reviewed. Physical, cultural, and religious factors affect gene pool mixing, making it impossible to predict a priori what the incidence of a given disorder will be within the population screened. This paper reviews the rationale for establishing neonatal metabolic screening programs and the significance of the information gained.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3945834     DOI: 10.1097/00007611-198601000-00014

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  2 in total

1.  Incidence and features of galactosaemia in Saudi Arabs.

Authors:  H Moammar; R Ratard; G Cheriyan; P Mathew
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

2.  Developmental timing of exposure to elevated levels of phenylalanine is associated with ADHD symptom expression.

Authors:  Kevin M Antshel; Susan E Waisbren
Journal:  J Abnorm Child Psychol       Date:  2003-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.